Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
6 hedge funds and large institutions have $1.2M invested in Medigus Ltd. Series C Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
55% more capital invested
Capital invested by funds: $772K → $1.2M (+$424K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ES
Equitec Specialists
Chicago,
Illinois
|
+$15.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$93K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$965 |
MDGSW Hedge Fund Activity: Q4 2020 in Review
6 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q4 2020, worth a combined $1.2M — up 55% from $772K a quarter earlier.
Fund positioning in MDGSW was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Equitec Specialists, adding an estimated $15.2K. The largest seller was Sabby Management, exiting entirely with an estimated $93K sold.
- 6 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $1.2M of Medigus Ltd. Series C Warrant stock for Q4 2020, up 55% quarter-over-quarter.
- 1 fund opened new Medigus Ltd. Series C Warrant positions in Q4 2020 and 1 closed out, a net change of 0 holders.
- The largest Medigus Ltd. Series C Warrant buyer in Q4 2020 was Equitec Specialists, an estimated $15.2K added.
- The largest Medigus Ltd. Series C Warrant seller in Q4 2020 was Sabby Management, an estimated $93K sold.
Based on aggregated 13F filings for Q4 2020.